SkinBioTherapeutics PLC (LSE:SBTX) - Share price


Stock Report

SkinBioTherapeutics PLC SBTX

Last Price
GBX14.50

Day Change
0.00|0.00%

As of 06/12/2019
14:11:11 GMT | GBX
Minimum 15 Minutes Delay.

Last Close14.50p
Day Range14.00 - 14.65
Mkt Cap18.57Mil
52-Wk Range12.00 - 26.00
Yield %-
ISINGB00BF33H870
Volume21,803
P/E-
P/SInfinity
P/CF-0.12

Share Price

Total Returns 06/12/2019

 Chg (%)  
More ...
SkinBioTherapeutics PLC-21.62 
FTSE 100 TR GBP-1.68
 
Financials
201720182019
More ...
Income Statement
Turnover---
Operating Profit-0.46-0.94-1.36
Net Profit-0.65-0.84-1.15
Reported EPS-1.11-0.71-0.94
Balance Sheet
Current Assets4.123.363.58
Non Current Assets0.220.290.35
Total Assets4.333.653.93
Current Liabilities0.120.210.12
Total Liabilities---
Total Equity4.213.443.81
Cash Flow
Operating Cash Flow-0.61-0.72-1.52
Net Change in Cash3.67-0.74-0.06
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
15/04/2019PurchaseDr. Catherine Denise Prescott17.8256,1129,999.00

Company Profile

SkinBioTherapeutics PLC is a life science company. The company is engaged in the development of technology to protect, manage and restore skin utilising proteins found in human microbiota.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 19/12/2019

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-35.71
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Financial Officer and Company SecretaryMr Douglas John Quinn
Non-Executive Director, ChairmanMr. Martin Braddock Hunt
Non-Executive DirectorDr. Catherine Denise Prescott
Executive Director, Chief Executive OfficerMr. Stuart John Ashman
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.